Aileron Therapeutics Inc expected to post a loss of 86 cents a share - Earnings Preview

Rein Therapeutics

07/04/2023 12:12

* Aileron Therapeutics Inc  ALRN.OQ   ALRN.O  is expected
to show
no change in quarterly revenue when it reports  results on April
10 (estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Aileron
Therapeutics Inc
is for a loss of 86 cents per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had risen by
about 1.5%
in the last three months. ​

This summary was machine generated April 7 at 11:12 GMT.  All
figures in US dollars  unless otherwise stated